Circumnavigating the challenges of COVID-19 in oncology

Affiliations

¹ Department of Medicine I and Comprehensive Cancer Center, Division of Clinical Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
² Internal Medicine V, Department of Hematology and Oncology, Medical University of Innsbruck, Anichstraße 35, 6020 Innsbruck, Austria.
³ Department of Oncology, Hematology and Palliative Care, Wilhelminen Hospital, Montleartstraße 37, 1160 Vienna, Austria.

Editorial

Thorsten Fuereder et al. Memo. 2020.

. 2020;13(2):135-138.

doi: 10.1007/s12254-020-00611-2. Epub 2020 May 7.

¹ Department of Medicine I and Comprehensive Cancer Center, Division of Clinical Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
² Internal Medicine V, Department of Hematology and Oncology, Medical University of Innsbruck, Anichstraße 35, 6020 Innsbruck, Austria.
³ Department of Oncology, Hematology and Palliative Care, Wilhelminen Hospital, Montleartstraße 37, 1160 Vienna, Austria.

No abstract available

Conflict of interest statement

Conflict of interestT. Fuereder, E. Gunsilius, R. Bartsch and W. Hilbe declare that they have no competing interests.

1. Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239. doi: 10.1001/jama.2020.2648. - DOI - PubMed
1. Hanna TP, Evans GA, Booth CM. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat Rev Clin Oncol. 2020 doi: 10.1038/s41571-020-0362-6. - DOI - PMC - PubMed
1. Oncopedia, editor. Oncopedia guidelines. 2020. https://www.onkopedia.com/de/onkopedia/guidelines/coronavirus-infektion-.... Accessed 19 Apr 2020.
1. European Society of Blood and Marrow Transplantation. 2020. https://www.ebmt.org/covid-19-and-bmt. Accessed 19 Apr 2020.
1. Calabro L, Peters S, Soria JC, et al. Challenges in lung cancer therapy during the COVID-19 pandemic. Lancet Respir Med. 2020;S2213-2600(20)30170-3 - PMC - PubMed